These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8150109)
1. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. le Cotonnec JY; Porchet HC; Beltrami V; Khan A; Toon S; Rowland M Fertil Steril; 1994 Apr; 61(4):669-78. PubMed ID: 8150109 [TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of recombinant human follicle-stimulating hormone. II. Single doses and steady state pharmacokinetics. le Contonnec JY; Porchet HC; Beltrami V; Khan A; Toon S; Rowland M Fertil Steril; 1994 Apr; 61(4):679-86. PubMed ID: 8150110 [TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers. le Cotonnec JY; Porchet HC; Beltrami V; Howles C Hum Reprod; 1993 Oct; 8(10):1604-11. PubMed ID: 8300814 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive pharmacokinetics of urinary human follicle stimulating hormone in healthy female volunteers. le Cotonnec JY; Porchet HC; Beltrami V; Khan A; Toon S; Rowland M Pharm Res; 1995 Jun; 12(6):844-50. PubMed ID: 7667188 [TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic-pharmacodynamic modeling after repeated subcutaneous administration. Porchet HC; le Cotonnec JY; Loumaye E Fertil Steril; 1994 Apr; 61(4):687-95. PubMed ID: 8150111 [TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. le Cotonnec JY; Porchet HC; Beltrami V; Munafo A Fertil Steril; 1998 Feb; 69(2):189-94. PubMed ID: 9496327 [TBL] [Abstract][Full Text] [Related]
7. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects. Matikainen T; De Leeuw R; Mannaerts B; Huhtaniemi I Fertil Steril; 1994 Jan; 61(1):62-9. PubMed ID: 8293846 [TBL] [Abstract][Full Text] [Related]
8. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials. Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone. Porchet HC; Le Cotonnec JY; Canali S; Zanolo G Drug Metab Dispos; 1993; 21(1):144-50. PubMed ID: 8095209 [TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Mannaerts B; de Leeuw R; Geelen J; Van Ravestein A; Van Wezenbeek P; Schuurs A; Kloosterboer H Endocrinology; 1991 Nov; 129(5):2623-30. PubMed ID: 1935792 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay. le Cotonnec JY; Porchet HC; Beltrami V; Munafo A Fertil Steril; 1998 Feb; 69(2):195-200. PubMed ID: 9496328 [TBL] [Abstract][Full Text] [Related]
12. Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides. LaPolt PS; Nishimori K; Fares FA; Perlas E; Boime I; Hsueh AJ Endocrinology; 1992 Dec; 131(6):2514-20. PubMed ID: 1446593 [TBL] [Abstract][Full Text] [Related]
13. Granulosa cell aromatase bioassay for follicle-stimulating hormone: validation and application of the method. Jia XC; Hsueh AJ Endocrinology; 1986 Oct; 119(4):1570-7. PubMed ID: 2428600 [TBL] [Abstract][Full Text] [Related]
14. In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP. Lambert A; Rodgers M; Mitchell R; Wood AM; Wardle C; Hilton B; Robertson WR Hum Reprod; 1995 Jul; 10(7):1928-35. PubMed ID: 8583012 [TBL] [Abstract][Full Text] [Related]
15. Metabolic clearance of human follicle-stimulating hormone assessed by radioimmunoassay, immunoradiometric assay, and in vitro Sertoli cell bioassay. Urban RJ; Padmanabhan V; Beitins I; Veldhuis JD J Clin Endocrinol Metab; 1991 Oct; 73(4):818-23. PubMed ID: 1909706 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. le Cotonnec JY; Loumaye E; Porchet HC; Beltrami V; Munafo A Fertil Steril; 1998 Feb; 69(2):201-9. PubMed ID: 9496329 [TBL] [Abstract][Full Text] [Related]
17. Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone. Zambrano E; Barrios-de-Tomasi J; Cárdenas M; Ulloa-Aguirre A Mol Hum Reprod; 1996 Aug; 2(8):563-71. PubMed ID: 9239668 [TBL] [Abstract][Full Text] [Related]
18. The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women. Karlsson MO; Wade JR; Loumaye E; Munafo A Br J Clin Pharmacol; 1998 Jan; 45(1):13-20. PubMed ID: 9489588 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines. Galway AB; Hsueh AJ; Keene JL; Yamoto M; Fauser BC; Boime I Endocrinology; 1990 Jul; 127(1):93-100. PubMed ID: 2141816 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin. Di Stefano AF; Rusca A; Radicioni MM; Loprete L; Binelli D; Caccia G; Cometti B Clin Drug Investig; 2016 Dec; 36(12):1031-1044. PubMed ID: 27638053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]